NNAAL linked to higher rates of NICU admission, preterm birth, eclampsia for mothers and infants.
A recent study conducted in Milwaukee revealed that mothers with a non-narcotic analgesics allergy label (NNAAL) face higher rates of NICU admissions, preterm births, and eclampsia. These mothers and their infants are more likely to experience adverse outcomes compared to those without the allergy label. The findings, released on Feb. 21, 2026, highlight the significant impact of NNAAL on maternal and infant health.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments